HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


P&G Ventures Startup Incubator Yields Supplements For Menopause Symptoms

Executive Summary

P&G Ventures startup's partnership with venture capital group M13 delivered its first brand, the Kindra four-product, hormone-free menopausal line. Kindra says its products provide relief from the seven symptoms of menopause in a market largely neglected.

You may also be interested in...

DuPont, P&G Aim To Accelerate Probiotic Sales By Developing ‘Next Generation’ Ingredients

DuPont says it and P&G “have conducted extensive research on human commensals bacteria to help address metabolic health issues in humans.” The partnership "will help us further advance our probiotic innovation via a next generation solution that will prove beneficial to the health and well-being of consumers around the world,” says Paul Gama, P&G personal health care president.

UK's DDD Helps Women ‘Flourish Through The Menopause’

DDD Ltd has launched under the Flourish brand five new women’s health products in the UK to "liberate" women from the challenges caused by the menopause.

Wellness Market Product Launches: Rejuvant, USANA, ZBiotics, Comvita Kids, Knosh, 7-Eleven, ERApeutics

USANA adds probiotics in oral care, launches menopause supplement; ZBiotics probiotics engineered for hangovers; Comvita launches Manuka honey children's cough/cold drops; Knosh supplements for sleep, mood and energy; 7-Eleven competes in energy drinks sector; ERApeutics has walnut milk for brain health; and Rejuvant LifeTabs for longer 'healthspan.'

Related Content


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts